Biological E.
Biological E. Limited is an Indian biopharmaceutical company focused on vaccines, biologics, branded formulations and specialty generic injectables. The organization operates R&D and manufacturing activities across vaccine antigen production, formulation development, analytical testing, fill–finish and quality systems, and maintains pharmacovigilance and clinical development capabilities. Headquarters and multiple manufacturing/R&D sites are located in and around Hyderabad, India.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Method for separation of protein and other impurities from microbial capsular polysaccharides
US-11680111-B2
View Details
Method for separation of protein and other impurities from microbial capsular polysaccharides
US-11680111-B2
View DetailsProducts
Vaccine portfolio (multiple indications)
A portfolio of vaccines and conjugate/combination formulations covering bacterial and viral diseases and public-health indications (examples referenced include diphtheria/tetanus, hepatitis, pentavalent combinations, Hib conjugates, measles & rubella, pneumococcal conjugates, Japanese encephalitis, typhoid conjugate and SARS‑CoV‑2 vaccines).
Measles Vaccine
Measles vaccine currently in the pipeline.
MRBEV Measles & Rubella Vaccine
Measles and rubella combination vaccine.
CORBEVAX
A protein subunit vaccine containing the receptor binding domain (RBD) of the SARS-CoV-2 virus, formulated with CpG1018 and aluminium hydroxide adjuvants for enhanced antibody and cellular immune responses.
COVID-19 Vaccine
COVID-19 vaccine candidate currently in the pipeline.
JEEV Japanese Encephalitis Vaccine Inactivated
Inactivated Japanese encephalitis vaccine.
Vaccine portfolio (multiple indications)
A portfolio of vaccines and conjugate/combination formulations covering bacterial and viral diseases and public-health indications (examples referenced include diphtheria/tetanus, hepatitis, pentavalent combinations, Hib conjugates, measles & rubella, pneumococcal conjugates, Japanese encephalitis, typhoid conjugate and SARS‑CoV‑2 vaccines).
Measles Vaccine
Measles vaccine currently in the pipeline.
MRBEV Measles & Rubella Vaccine
Measles and rubella combination vaccine.
CORBEVAX
A protein subunit vaccine containing the receptor binding domain (RBD) of the SARS-CoV-2 virus, formulated with CpG1018 and aluminium hydroxide adjuvants for enhanced antibody and cellular immune responses.
COVID-19 Vaccine
COVID-19 vaccine candidate currently in the pipeline.
JEEV Japanese Encephalitis Vaccine Inactivated
Inactivated Japanese encephalitis vaccine.
Services
Manufacture and supply of vaccine antigens and biologics across bacterial and viral platforms, including antigen production, purification and fill–finish.
Development, formulation and manufacture of branded pharmaceutical formulations and specialty injectable generics, including complex injectables and platform technologies (e.g., microspheres, nanoformulations).
Manufacture and supply of vaccine antigens and biologics across bacterial and viral platforms, including antigen production, purification and fill–finish.
Development, formulation and manufacture of branded pharmaceutical formulations and specialty injectable generics, including complex injectables and platform technologies (e.g., microspheres, nanoformulations).
Expertise Areas
- Vaccine development and manufacturing
- Bioprocessing and scale-up
- Analytical and immunoassay development
- Quality assurance and GxP compliance
Key Technologies
- Upstream fermentation
- Cell culture
- Virus culture
- Downstream purification / chromatography